Abivax (ABVX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABVX.FP | ||||
| Company | Abivax | ||||
| Price Information | |||||
| Exchange | Euronext FR | ||||
| Open | 103.800 | ||||
| High | 107.800 | ||||
| Low | 103.200 | ||||
| Latest | 107.200 | ||||
| Change | +6.000 | ||||
| % Change | +5.93% | ||||
| Volume | 120,238 | ||||
| 20-Day Average Volume | 124,311 | ||||
| Previous Close | 101.200 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 103.455 | ||||
| 20-Day Raw Stochastic | 71.81% | ||||
| 20-Day Relative Strength | 54.59 | ||||
| Weighted Alpha | +147.53 | ||||
| Today's Opinion | 96% Buy | ||||
| Previous Opinion | 56% Buy | ||||
| Last Month's Opinion | 72% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.96% since 03/09/26 | ||||
| Low | 96.200 on 03/11/26 | ||||
| High | 113.600 on 03/12/26 | ||||
| 1-Month | |||||
| %Chg | -0.37% since 02/16/26 | ||||
| Low | 90.900 on 03/09/26 | ||||
| High | 113.600 on 03/12/26 | ||||
| 3-Month | |||||
| %Chg | +13.92% since 12/16/25 | ||||
| Low | 90.100 on 02/02/26 | ||||
| High | 132.000 on 01/12/26 | ||||
| 6-Month | |||||
| %Chg | +56.27% since 09/16/25 | ||||
| Low | 66.800 on 09/18/25 | ||||
| High | 132.000 on 01/12/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 7,432,827 | ||||
| Shares Outstanding, K | 79,073 | ||||
| Annual Sales | 0 | ||||
| Annual Net Income | -176,242,000 | ||||
| Last Quarter Sales | 0 | ||||
| Last Quarter Net Income | -153,358,000 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | -2.10 on 12/15/25 | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||